Tiago Zaninelli

Biologist | PhD in Experimental Pathology
PostDoc at WashU - Ribeiro Lab

[Tiago Zaninelli @TiagoZaninelli]

5/5 Thank you to all involved. Special thanks to @victor_fattori and Olivia Heintz!

[Tiago Zaninelli @TiagoZaninelli]

1/5 I’m happy to share our new paper on #endometriosis and #neurotrophic #factors in @jarcuhala .
This study was developed during my PhD at the #Rogers Lab @BostonChildrens @harvardmed in collaboration with the @VerriLab .
https://t.co/eU2l7wfZhS

[Tiago Zaninelli @TiagoZaninelli]

4/5 Therefore, NGF-TrkA axis blockade is a potential therapeutic approach for endometriosis.

[Ribeiro Lab @NeurobiomeLab]

Check out our new review @TrendsImmuno by Telma and Tiago!

Modulation of host immunity by sensory neurons: Trends in Immunology https://t.co/gUoblOThYR

[Tiago Zaninelli @TiagoZaninelli]

Congrats @victor_fattori for your great contributions to the fields of #endometriosis and #neuroimmunology. I'm honored to be part of it.

[Victor Fattori @victor_fattori]

#Preprint Alert 🚨‼️

I'm happy to share the results of my first post doc work entitled "Nociceptor to #macrophage communication through CGRP/RAMP1 signaling drives #endometriosis-associated #pain and lesion growth"

Online now in #bioRxiv
https://t.co/mqvq7D3KwJ

[bioRxiv Neuroscience @biorxiv_neursci]

Nociceptor to macrophage communication through CGRP/RAMP1 signaling drives endometriosis-associated pain and lesion growth https://t.co/R1IztAB0gX #biorxiv_neursci

[Victor Fattori @victor_fattori]

Happy to share the latest (and most likely the last) paper from my #PhD in the @VerriLab. Maresin 2, a pro-resolving lipid, blocks TRPV1 and TRPA1 activation as well as neutrophil and monocyte recruitment to reduce inflammatory #pain.

Check it out 👉https://t.co/S0qtDK0QqY

[Tiago Zaninelli @TiagoZaninelli]

I'm thrilled with my Ph.D.'s thesis results. Thanks to all involved!
@victor_fattori @VerriLab @Telma094811591 @StehhGarcia1 @camila_rferraz @marianabertozzi @larissasferrari @RasquelOliveira @anitellinay

[Tiago Zaninelli @TiagoZaninelli]

I’m excited to share our new publication in the British Journal of Pharmacology.
@BritPharmSoc @BrJPharmacol @ueloficial

https://t.co/HfNTOpX3G0

[Tiago Zaninelli @TiagoZaninelli]

Our study also shed light on the role of CGRP in gout, establishing an important neuroimmune axis hitherto unknown in gout pathophysiology mechanism.

[Victor Fattori @victor_fattori]

4 seasons @BostonChildrens

[Victor Fattori @victor_fattori]

📢Looking for a postdoc position in endometriosis? The lab of Dr. Michael Rogers @BostonChildrens / @harvardmed is recruiting a postdoctoral fellow to work in an exciting and funded project to elucidate how CMG2 regulates angiogenesis and affects pain during endometriosis.

[Frontiers - Physiology @FrontPhysiol]

New Research: Harnessing Inflammation Resolution in Arthritis: Current Understanding of Specialized Pro-resolving Lipid Mediators’ Contribution to Arthritis Physiopathology and Future Perspectives https://t.co/72fjDqdPfn #Physiology

[Tiago Zaninelli @TiagoZaninelli]

We also review the therapeutic potential of #SPMs in pre-clinical studies and futures perspectives in the field. Check it out https://t.co/RGvVF7hnKq! More to come🤞🏻 @victor_fattori #ladinc #labdor #SPMs

[Tiago Zaninelli @TiagoZaninelli]

I’m very excited to announce my first first-authored paper from my #PhD. The #review article: "Harnessing inflammation resolution in arthritis: current understanding of specialized pro-resolving lipid mediators' contribution to arthritis #physiopathology and future #perspectives"

[Tiago Zaninelli @TiagoZaninelli]

It is #accepted, and will be fully available shortly at @FrontPhysiol. In this review we talk about the fluctuation in SPMs levels and its contribution to arthritis physiopathology, disease status, and symptoms in humans and mice.

[Victor Fattori @victor_fattori]

Sdds @dilmabr